Charité Universitätsmedizin Berlin - Campus Benjamin Franklin

Berlin D-12200

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Traumatic Brain Injury

Studies at this site

• A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy — Running, not enrolling
• Evaluation of Biomarkers of Traumatic Brain Injury — Completed